The syncytial mutant of herpes simplex virus type 1 (HSV-1), HSV-1 (13) S 11, which carries three distinct syncytial mutations, Syn 1, Syn 5 and Syn 6, was described previously. Syn 1 maps to the BamHI L fragment, map units (m.u.) 0-707 to 0.745; Syn 5 is located within the BamHI Q fragment, m.u. 0.296 to 0.317; Syn 6 lies in the junction fragment BamHI SP, m.u. 0.81 to 0-85. Although Syn 1 of HSV-I(13) Sll seems to be homologous to that of HSV-I(MP) and other syncytial mutants, and Syn 5 has been recently characterized, Syn 6 represents a novel syncytial locus which has yet to he characterized. In this paper we report the fine mapping of the Syn 6 locus. This mutation has been mapped, by marker rescue and marker transfer experiments, to the long repeat regions (RE) at both ends of the L component of the HSV genome in a restriction endonuclease fragment of approximately 1-6 kb designated BamHI-SacI C (approximate m.u. 0.01 to 0.02 and 0.81 to 0.82). In the internal copy of R E the sequences containing the Syn 6 mutation were bounded to the left by the 5' end of the ~ gene specifying ICPO and to the right by the ~1 gene encoding ICP34.5.
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Polykaryocyte formation caused by herpes simplex virus (HSV) infection in a given cell line can be determined by at least six syn loci, Syn 1 to 6, in the viral genome (Tognon et al., 1988; Spear, 1984) . The mutations corresponding to these loci map to different regions of the L component of HSV DNA; however, only three of the genes involved are known or have been characterized. The Syn 3 mutation affects the 3' end of the glycoprotein B (gB) gene (DeLuca et al., 1982; Kousoulas et al., 1984) ; the Syn 1 mutation alters the gene encoding the recently discovered glycoprotein K (gK) (D. Snoddy, personal communication); the Syn 5 mutation seems to affect the UL24 gene, the product of which has not been characterized (Jacobson et al., 1990; Tognon et al., 1991) . Loci Syn 2, Syn 4 and Syn 6 have been mapped, but little is known about the genes altered by these mutations or the proteins encoded (Ruyechan et al., 1979; Little & Schaffer, 1981 ; Tognon et al., 1988) . In addition to the six syn loci, at least two other HSV gene products, glycoproteins gD and gH, play a role in the induction of cell fusion; anti-gD and anti-gH monoclonal antibodies block polykaryocyte formation in HSV-infected cells (Noble et al., 1983; Gompels & Minson, 1986) .
In this paper we report the fine mapping of the Syn 6 locus identified in the syn mutant HSV-1 (13) S 11, which carries three independent syncytial lesions, Syn 1, Syn 5 and Syn 6 (Tognon et al., 1988) . Previously, we have shown that this syn mutant induces fusion in different infected cell lines, such as HEp-2, Vero, BHK and HEL. However, when the three syn loci are assayed independently for their ability to induce cell fusion, only the Syn 6 locus is able to induce syncytium formation in all cell lines (Tognon et al., 1988) . This HSV-I(13) Sll syn mutation is located between map units (m.u.) 0.81 and 0.85, as determined by marker transfer experiments performed with the large cloned fragment BamHI SP. This fragment contains the junction region of the L and S components of the genome, in which at least three diploid genes map (in part or completely): the ~0 or immediate early (IE) gene 1 (Jones et al., 1977; Anderson et al., 1980) , ~1 34.5 gene (Chou & Roizman, 1990) , and the ct4 or IE gene 3 (Rixon et al., 1982) (Fig. 1) .
To determine whether the mutation of the Syn 6 locus is located in the L or the S component of the HSV genome, marker rescue experiments were carried out. Rabbit skin or Vero cell monolayers were transfected by the calcium phosphate precipitation method (Graham & van der Eb, 1973 ) with a mixture of intact DNA from HSV-1 (13) S 11 and two subclones of BamHI SP, BamHI S (pRB143) and BamHI P (pRB145) (Mocarski & Roizman, 1982) . The progeny obtained were titrated on HEp-2 monolayers to screen for recombinant viruses 
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exhibiting the syn + phenotype. The efficiency of marker rescue was calculated as the number of syn ÷ plaques in the total number of plaques. The marker rescue data, which are summarized in Table 1 , indicate that only BamHI S rescued the mutation of the Syn 6 locus; this region contains the repeat sequences of the L component only. Specifically, the BamHI S fragment (approximately 2-8 kb) contains part of the s0 gene encoding the transactivator protein ICP0 (Everett, 1987) and the sequences encoding ICP34.5, which is related to neurovirulence . We investigated the infected cell proteins (ICP) which accumulated in HEp-2 cells infected with HSV-I(13) Sll (Tognon et al., 1984) , the parental strain HSV-I(13) (Cassai et al., 1972) , and the prototype HSV-I(F) (Ejercito et al., 1968) and a deletion mutant derived from it, R3631 (Mavromara-Nazos et al., 1986) , which lacks the ~47 gene. The last two strains were used as controls.
To determine whether HSV-1 (13) S 11 was defective in ICP0, we compared the ~ gene products of the viruses by SDS-PAGE. Viral ~ protein synthesis analysis was done by preincubation of the HEp-2 cells with 50 ~tg cycloheximide/ml of medium for 30 min before infection with 20 p.f.u./cell; the incubation was continued for 5 h in cycloheximide. The drug was then removed, the cells were labelled with 100 ~tCi [35S]methionine/ml for 20 min, and infected cells were harvested, solubilized in SDS disruption buffer and subjected to electrophoresis in a 9-5 to 17~ SDS-polyacrylamide gradient gel (Tognon et al., 1991) .
A slight difference in the electrophoretic migration of ICP0 from HSV-I(13) and HSV-I(13) S11 was observed (Fig. 2) . A putative new ~ polypeptide or an induced host cell polypeptide with an Mr of approximately 16K was detected in HSV-l-infected cells (Fig. 2) . Since the samples were compared to the ~47-mutant R3631, which does not accumulate ICP47 (12K), the 16K 21.5K
14-4K Fig. 3 . Autoradiograms of polypeptides extracted from HEp-2 cells infected with HSV-I(13) (odd-numbered lanes) and HSV-I(13) SI1 (even-numbered lanes) separated electrophoretically. The polypeptides were labelled for 2 h at different times (lanes 1 and 2, 1 to 3 h; lanes 3 and 4, 3 to 5 h; lanes 5 and 6, 5 to 7 h; lanes 7 and 8, 7 to 9 h; lanes 9 and 10, 9 to 11 h; lanes 11 and 12, 11 to 13 h; lanes 13 and 14, 13 to 15 h; lanes 15 and 16, 15 to 18 h) and separated on a 9.25 to 15~ SDSpolyacrylamide gradient gel. Lane M, mock-infected HEp-2 cell extracts.
polypeptide is unlikely to be ICP47 (Fig. 2) . The 16K polypeptide has been designated ICP46. This analysis was then extended to the late gene products. Briefly, cell monolayers infected with 10 p.f.u./cell were labelled for 2 h with 20 rtCi/ml [3SS]methionine or 1 ~tCi/ml 14C-labelled amino acid mixture and cell extracts were electrophoresed in 8.5 to 1 5~ SDSpolyacrylamide gradient slab gels cross-linked with N,N'-diallyltartardiamide. The experimental results indicated that some HSV-I(13) Sll late polypeptides exhibit an altered electrophoretic mobility compared to those of the wild-type strain. Also, mutant HSV-I(13) S11, which lacks glycoprotein C (gC-) (Tognon et al., 1984) , does not synthesize ICPI 5, the 105K precursor of gC; three other structural proteins, ICP23, ICP32 and ICP35, were also defective. It appeared that the kinetics of accumulation of these polypeptides were slower than those of the homologous polypeptides of the parental strain, but similar concentrations were reached late in infection (Fig. 3) . In addition, y ICP44 and 13 ICP45 from the two strains did not comigrate. Indeed, ICP44 and ICP45 from HSV-I(13) S11 migrated slower and faster, respectively, than the homologous proteins from the parental strain (Fig. 3) . The difference in the migration of ICP44 might be due to the heterogeneity of this polypeptide (Lonsdale et al., 1979) .
To map the syn mutation in this region in more detail, the B a m H I SP fragment of HSV-I(13) S11 was digested with both B a m H I and SacI. Fig. 1 shows the five fragments, B, C, D, E and H, produced by the double digestion. Subsequently, these five fragments were assayed independently for their ability to transfer the syn phenotype to wild-type strains, namely isogenic strain 13 and the non-isogenic HSV-2(G) strain (Ejercito et al., 1968) .
The results of marker transfer (Table 2) indicated that only B a m H I -S a c I C, of approximately 1.6 kb, was able to transfer efficiently the syn mutation of locus Syn 6. It is worth mentioning that, of the known genes mapped to these sequences, this locus contains the 5' end of the ~0 gene (Perry & McGeoch, 1988) and the putative polyadenylation signal of the 71 34.5 gene (Chou & Roizman, 1990) . To confirm the marker transfer data, the B a m H I -S a c I C fragments obtained from the mutant and parental strains were cloned and then retested for their ability to transfer the syn mutation.
The result of this assay confirmed that, although the sequences contained in the B a m H I -S a c I C fragment of HSV-I(13) S11 were able to transfer the mutation to the genome of the parental strain, HSV-1 (13) or HSV-2(G), the homologous fragment obtained from HSV-I(13), used as a control, failed to transfer the Syn 6 mutation (Table 3) . Interestingly, the marker transfer frequency obtained using the non-isogenic HSV-2(G) was higher than that using the isogenic HSV-1 (13), perhaps because the type 2 genome contains sequences that act as recombinational hotspots. fragment ( To score the recombinants obtained from the transfections using the BamHI-SacI C fragment of HSV-I(13) S11 as a donor fragment and the whole genome of wildtype strains as recipient DNA, the progeny virus was assayed on HEp-2 cells. Indeed, of the three syn mutations present in HSV-I(13) S1 l, only that of the Syn 6 locus induced polykaryocytes in HEp-2 cell monolayers as well as in three other cell lines, Vero, BHK and HEL (Tognon et al., 1988) .
Short communication
The intratypic recombinants, HSV-1 (13) x HSV-1 (13) Sll, had the fusogenic activity characteristic of the donor mutant strain, i.e. they produced fusion of both HEp-2 and Vero cells; the intertypic recombinants, HSV-2(G) x HSV-I(13) Sll, although they produced fusion of HEp-2 cells, did not do so for Vero cells, in which the phenotype appeared to be syn ÷.
The BamHI-SacI C fragment contains sequences from the 5' end of the s0 gene and probably the polyadenylation signal of the yl 34.5 gene. On this basis, we assume that the gene product responsible for the syn phenotype is ICP0 or ICP34.5. Recently, it has been shown by Everett (1987) that deletions in the 0t0 gene generate mutants which produce small plaques. If ICP0 is the altered polypeptide of the Syn 6 locus of HSV-I(13) S11, one may postulate that polykaryocyte formation is the result of a pleiotropic effect. Indeed, this early gene product, the function of which is the trans-activation of late genes, may be defective, perhaps causing the accumulation of one or more late polypeptides with fusogenic activity to be delayed in both infected cells and mature virions. This interpretation is supported by the results obtained from SDS-PAGE of late ICPs, which showed delayed accumulation of at least three different structural polypeptides. The virion and the cell surface may contain unbalanced amounts of structural polypeptides, which could result in the syncytial phenotype.
The mutation present in the BamHI-SacI C fragment may affect the 3' non-coding region of the 2,1 34.5 gene and as a result its expression may be altered. However, the yl 34.5 gene is dispensable in tissue culture and is related to neurovirulence. Therefore, it is unlikely that this gene product produces the syn phenotype. Alternatively, the sequences of the Syn 6 locus may carry an as yet unidentified gene, which overlaps with the or0 gene, or lies in the 1 kb region between the 5' end of the s0 gene and the SacI site, the product of which is involved in fusion.
